메뉴 건너뛰기




Volumn 341, Issue 7770, 2010, Pages

Orphan drugs: Relating price determination to disease prevalence

Author keywords

[No Author keywords available]

Indexed keywords

ORPHAN DRUG;

EID: 84859005778     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c4615     Document Type: Letter
Times cited : (22)

References (5)
  • 1
    • 49749093425 scopus 로고    scopus 로고
    • Orphan diseases: Which ones do we adopt?
    • (11 August.) [FREE Full text]
    • Richards T. Orphan diseases: which ones do we adopt? BMJ 2008;337:a1225. (11 August.) [FREE Full text]
    • (2008) BMJ , vol.337
    • Richards, T.1
  • 3
    • 33747050446 scopus 로고    scopus 로고
    • Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products
    • DOI 10.1111/j.1365-2125.2006.02654.x
    • Dear JW, Lilitkarntakul P, Webb DJ. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products. Br J Clin Pharmacol 2006;62:264-71. [CrossRef] [Medline] [Web of Science] (Pubitemid 44215525)
    • (2006) British Journal of Clinical Pharmacology , vol.62 , Issue.3 , pp. 264-271
    • Dear, J.W.1    Lilitkarntakul, P.2    Webb, D.J.3
  • 4
    • 27644486590 scopus 로고    scopus 로고
    • Orphan drugs and the NHS: Should we value rarity?
    • McCabe C, Claxton K, Tsuchiya A. Orphan drugs and the NHS: should we value rarity? BMJ 2005;331:1016-9. [FREE Full text] (Pubitemid 41552456)
    • (2005) British Medical Journal , vol.331 , Issue.7523 , pp. 1016-1019
    • McCabe, C.1    Claxton, K.2    Tsuchiya, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.